180 related articles for article (PubMed ID: 7932149)
1. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
Negus SS; Butelman ER; Chang KJ; DeCosta B; Winger G; Woods JH
J Pharmacol Exp Ther; 1994 Sep; 270(3):1025-34. PubMed ID: 7932149
[TBL] [Abstract][Full Text] [Related]
2. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
Pakarinen ED; Woods JH; Moerschbaecher JM
J Pharmacol Exp Ther; 1995 Feb; 272(2):552-9. PubMed ID: 7853168
[TBL] [Abstract][Full Text] [Related]
3. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
4. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
Negus SS; Burke TF; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
Comer SD; McNutt RW; Chang KJ; De Costa BR; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):866-74. PubMed ID: 8246161
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
[TBL] [Abstract][Full Text] [Related]
7. A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
Dykstra LA; Schoenbaum GM; Yarbrough J; McNutt R; Chang KJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):875-82. PubMed ID: 8246162
[TBL] [Abstract][Full Text] [Related]
8. Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
Negus SS; Mello NK; Portoghese PS; Lukas SE; Mendelson JH
J Pharmacol Exp Ther; 1995 Jun; 273(3):1245-56. PubMed ID: 7791097
[TBL] [Abstract][Full Text] [Related]
9. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
[TBL] [Abstract][Full Text] [Related]
10. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Su YF; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
[TBL] [Abstract][Full Text] [Related]
11. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
12. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
Comer SD; Hoenicke EM; Sable AI; McNutt RW; Chang KJ; De Costa BR; Mosberg HI; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):888-95. PubMed ID: 8246164
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
Brandt MR; Negus SS; Mello NK; Furness MS; Zhang X; Rice KC
J Pharmacol Exp Ther; 1999 Sep; 290(3):1157-64. PubMed ID: 10454490
[TBL] [Abstract][Full Text] [Related]
14. Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.
Negus SS; Morgan D; Cook CD; Picker MJ
Psychopharmacology (Berl); 1996 Aug; 126(3):199-205. PubMed ID: 8876019
[TBL] [Abstract][Full Text] [Related]
15. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
Stevenson GW; Folk JE; Rice KC; Negus SS
J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
[TBL] [Abstract][Full Text] [Related]
16. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
Torregrossa MM; Isgor C; Folk JE; Rice KC; Watson SJ; Woods JH
Neuropsychopharmacology; 2004 Apr; 29(4):649-59. PubMed ID: 14647482
[TBL] [Abstract][Full Text] [Related]
17. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
Chang KJ; Rigdon GC; Howard JL; McNutt RW
J Pharmacol Exp Ther; 1993 Nov; 267(2):852-7. PubMed ID: 8246159
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice.
O'Neill SJ; Collins MA; Pettit HO; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):271-7. PubMed ID: 9223564
[TBL] [Abstract][Full Text] [Related]
19. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
France CP; Gerak LR
J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
